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Abstract
Background/Aim: The prevalence of pulmonary hypertension (PH) is reported between 17 and
56% in hemodialysis (HD) patients. Pathogenesis of PH in HD patients is still unclear.
Malnutrition associating impaired pulmonary function tests in HD patients previously reported.
Present study aimed to investigate an association between PH and nutrition and inflammation
HD patients. Patients/Methods: Total 179 HD patients (109M, 70 F) were included. Pulmonary
artery pressure (PAP) and ejection fraction (EF) percentage was determined by echocardiog-
raphy after a midweek HD session. Bioimpedance analyses were performed after dialysis.
Percent body fat mass truncal fat (%), total body water (%), body-mass index was determined.
Serum 25-OH vitamin D, albumin, lipid parameters, C-reactive protein (CRP), calcium,
phosphorus, parathyroid hormone, ferritin levels, and hemogram were studied. Results:
Pulmonary hypertension (PAP435mmHg) was found in 48 (26.8%) of 179 patients studied.
Body-mass index (BMI) was negatively correlated with PAP (r¼0.34; p¼ 0.02). HD vintage,
prevalence of diabetes, sex, type of vascular access were not different between patients with
PH and without PH. Patients with PH were older (68.1 ± 14.4; 61.3 ± 14.7; p¼ 0.005). Percent
body fat (19.8 ± 8.1% vs. 28.1 ± 10%; p¼ 0.001), albumin (3.4 ± 0.5 g/dl vs. 3.9 ± 3.3 g/dl;
p¼ 0.0001), truncal fat (16.8 ± 10.7 vs. 26.4 ± 10.5; p¼ 0.001), triglyceride (147.9 ± 88.5 vs.
182.1 ± 97.7mg/dl; p¼ 0.03), and total cholesterol (146.9 ± 34.5 vs. 169.5 ± 43mg/dl; p¼ 0.004)
levels were significantly lower in patients with PH than with no PH. Logistic regression analysis
revealed that increased percent body fat, albumin, and total cholesterol associate with a
decreased risk of PH. Conclusion: Present study demonstrated a significant association between
malnutrition and PH in HD patients. Those results should be confirmed by further prospective
studies including cytokine levels and spirometric measurements.
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Introduction
Pulmonary hypertension (PH) is a complex hemodynamic
alteration which may result from disparate causes, is described
as an increase in mean pulmonary arterial pressure (mPAP
25 mmHg). PH in chronic kidney disease (CKD) is classified
as a different group (Group 5) which consists of PH with
unclear and/or multifactorial mechanisms.1,2 Cardiac catheter-
ization revealed a prevalence of PH in 71% of patients with pre-
dialysis CKD and 77% of hemodialysis (HD) patients having
dyspnea unexplained by other causes.3 Studies based on
echocardiography detected prevalences of PH between 17 and
56% in patients with end-stage renal disease (ESRD).4–9
PH is a newly emerging entity in HD patients. The
mortality rate of HD patients with elevated pulmonary artery
pressure (PAP) has been found to be significantly higher than
those patients with normal PAP.4 Numerous clinical,
hemodynamic, and metabolic abnormalities, such as anemia,
fluid overload, and increased CO because of AV fistula,
oxidative stress, and alterations in the release of vasoactive
mediators, such as endothelin-1 (ET-1) and nitric oxide (NO),
have been suggested to have a significant role in the
pathogenesis of PH in HD patients.4,10–12 A chronic inflam-
matory state is a prominent feature in ESRD patients who are
undergoing maintenance HD.13 A high prevalence of protein
energy malnutrition leading to systemic inflammation has
been shown in those patients also. Previously Ulubay et al.14
demonstrated a negative correlation between pulmonary
functions (FEV1, FVC, FEF25–75%, PEF) and malnutrition
inflammation score in HD patients. Another prospective study
on maintenance of HD patients revealed lower albumin but
similar C-reactive protein (CRP) levels in patients with PH
than with no pulmonary hypertension.15
The aim of the present study is to investigate the
prevalence of PH and a possible association between
pulmonary hypertension and nutritional, biochemical, inflam-
matory markers, and body composition in long-term HD
patients.
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Patients and methods
Total of 179 HD patients (109 M, 70 F) who were on HD at
least for six months were involved in this study. All patients
involved were on regular 4 h thrice weekly regular HD at
Baskent University Alanya Hospital Hemodialysis Unit via
arteriovenous fistula using same method of cannulation and
biocompatible polysulphone high-flux dialyzers (Allmed
Polypure 1.8–2 m2, Allmed Medical GmbH, Dresden,
Germany). Dialysate flow rates were 500–800 mL/min
and blood flow rates were between 250 and 400 mL/min.
Of the 179 patients, 51 patients (28.5%) had diabetes and
128 patients (73.7%) had no diabetes at the time of the
study. Primary kidney diseases were diabetic
nephropathy in 48 (26.8%), hypertension in 49 (27.3%),
chronic glomerulonephritis in 29 (16.2%), nephrolithiasis in
9 (5.1%), polycystic kidney disease in 9 (5%), unknown in
19 (10.6%), obstructive nephropathy in 12 (6.7%), amyloidosis
in 4 (2.3%).
Exclusion criteria
Patients with known acute or chronic pulmonary disease or
known history of smoking, clinical diagnosis of decompen-
sate cardiac failure or measured ejection fraction below 40%
before the study, coronary artery disease or by-pass surgery,
chronic atrial fibrillation, were excluded. Patients who missed
two or more HD sessions in the last one month, abused drugs,
body-mass index (BMI)  40 kg/m2 were excluded. Patients
who had a change in dry weight or anti-hypertensive
medications within two weeks were also excluded. Patients
with uncontrolled hyperphosphatemia, uncontrolled hyper-
tension, adherence problems to diet and medications, known
to have active malignant and inflammatory, infectious, or
hepatic diseases were excluded. None of the patients were
under treatment of steroids, fish-oil, active vitamin D, or
derivatives, at the time of the study. None of the patients had a
history of bone disease, active bone fracture, diseases causing
intestinal malabsorption.
Clinical and demographic data collection
Patient’s history of diabetes, rheumatism, cardiac, or vascu-
lar diseases, primary kidney diseases, smoking habits,
medications, and duration of HD were recorded at baseline
from patient interviews, and HD data sheets. Duration of
HD is recorded as months. Demographic characteristics
and basal laboratory results of the study group were
shown in Table 1. Dry body weight is taken as the mean of
last three pre-dialysis body weights. Body-mass index is
calculated with division of dry body weight (kg) to square of
height (m2).
Biochemical analyses
In all patients blood samples were drawn at a midweek HD
session from antecubital vein with standard method. 25-OH
(hydroxy) vitamin D levels were studied with chemilumines-
cent microparticle immunometric assay (Architect I 10/
Abbott, Abbott Laboratories, Abbott Park, IL). Intact PTH
was measured by chemiluminescence immunometric assays
using Siemens Immulite 2000 (Siemens Healthcare
Diagnostics, Deerfield, IL). Calcium, phosphorus, albumin,
and CRP tests were measured by standard laboratory methods
using the c8000 Architect (Abbott Laboratories, Abbott
Park, IL). Total cholesterol (TC), low-density lipoprotein
cholesterol (LDL-C), high-density lipoprotein cholesterol
(HDL-C), and plasma triglyceride (TG) concentrations were
undertaken using an oxidase-based technique by the Roche/
Hitachi modular system (Mannheim, Germany).
Bio impedance analysis
Basal metabolic rate, muscle mass, total fat mass and
percentage of total fat (%), truncal fat mass, percentage of
fat at upper and lower extremities separately measured by bio
impedance analysis method (Tanita Body Composition
Analyser, BC-418; Tanita Corp., Arlington Heights, IL).
Echocardiography
All patients underwent two-dimensional echocardiography
(Sonos 4500 HP; Hewlett-Packard Company, Palo Alto, CA)
with a 2.5 MHz multiphase array probe to assess cardiac
valvular calcification after dialysis at their dry body weight
during patients lying in left decubitus position. All echocar-
diographs were performed according to recommendations of
the American Society of Echocardiography and were
analyzed by a single experienced cardiologist who was
blinded to all clinical details.16 In all patients, PAP was
obtained by adding the estimated right atrial pressure to the
tricuspid regurgitation velocity 2 4. The right atrial pressure
was estimated as 5 mmHg if there was no engorgement in
inferior vena cava (more than 50% difference in diameter by
tidal inspiration). It was assumed as 10 mmHg, if there was
less than 50% difference in diameter of inferior vena cava.
PAP435 mmHg is defined as pulmonary hypertension which
is generally accepted.17–19
Table 1. Baseline clinical, demographic, and laboratory characteristics
of study group.
Minimum Maximum Mean
Std.
Deviation
Age 36 95 60.7 15.9
Body weight (kg) 56.8 111.8 70.2 16.0
BMI 16.8 46.8 27.3 5.1
Percent body fat (%) 16.0 47.0 26.6 10.2
Total body water (L) 19.0 54.5 37.3 8.3
25-OH vitamin D (mg/L) 4.1 37.0 13.5 5.8
Calcium (mg/dL) 5.4 11.3 8.8 0.80
Phosphorus (mg/dL) 0.8 10.3 4.7 1.7
PTH (pg/mL) 83.0 524.0 242.3 291.2
Ferritin (ng/mL) 153.6 1344.0 724.7 482.8
Triglyceride (mg/dL) 97.0 390.0 177.4 100.6
Total cholesterol (mg/dL) 107.0 303.0 166.7 42.3
PAP (mmHg) 15 73.0 28.7 12.4
Left ventricular EF (%) 45 77.0 59.4 10.7
Dialysis vintage (months) 21 154.5 49 49.5
Kt/v 1.29 2.2 1.4 0.2
Albumin (g/dL) 2.7 5.2 3.7 2.5
C-reactive protein (mg/L) 4.5 44.1 19.1 25.6
Venous bicarbonate (meq/L) 17.7 25.8 20.8 2.8
Hemoglobin (g/dL) 10.1 14.9 11.5 1.2
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Indices of dialysis adequacy
Total weekly urea clearances of all patients were measured
using standard methods as described previously.20
Statistical analyses
Statistical analyses were performed by using software SPSS
11.0.1 (April 2002; IBM Corp., Armonk, NY). Assumption
of normal (Gaussian) distribution was tested by the One
Sample Kolmogorov-Smirnov test. Simple correlations were
performed using Pearson’s or Spearman’s correlation analyses
as appropriate. Comparisons of variables between groups
were performed Student’s t-test or Mann-Whitney U-tests in
accordance with the distribution pattern of variable. Binary
logistic regression analysis is used to determine independent
effects of variables on pulmonary hypertension.
Results
Baseline demographic characteristics and baseline laboratory
results of the study group are summarized in Table 1.
Echocardiography revealed pulmonary hypertension (PH:
PAP435 mmHg) in 48 (26.8%) patients.
Simple correlations
Pulmonary artery pressure was negatively correlated with BMI
(r¼0.34; p¼ 0.002), percentage of body fat (r¼0.316;
p¼ 0.004), truncal fat mass (r¼0.34; p¼ 0.002), pre-
dialysis body weight (r¼0.28; p¼ 0.01), dry (post-dialysis)
body weight (r¼0.3; p¼ 0.004), triglyceride (r¼0.23;
p¼ 0.005), total cholesterol (r¼0.26; p¼ 0.002) and albu-
min (r¼0.23; p¼ 0.0001) (Figure 1). PAP had no correl-
ation with CRP, hemoglobin, dialysis vintage, and Kt/v.
C-reactive protein levels was positively correlated with age
(r¼ 0.29; p¼ 0.0001), negatively correlated with albumin
(r¼0.465; p¼ 0.0001), hemoglobin (r¼0.31; p¼ 0.001)
and 25-hiydroxy vitamin D levels (r¼0.221, p¼ 0.02).
Albumin had positive correlations with triglyceride
(r¼ 0.3; p¼ 0.0001), hemoglobin (r¼ 0.23; p¼ 0.01).
Dialysis vintage had a negative correlation with total muscle
mass (r¼0.27; p¼ 0.02).
Figure 1. Correlations between PAP (mmHg) and albumin (g/dL), total cholesterol (mg/dL) levels and body fat percent (%).
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Comparison of the body composition, nutritional, inflam-
matory, and metabolic parameters between HD patients
having PH and with no pulmonary hypertension revealed
that patients with PH were older (68.3 ± 14.4 vs. 61.3 ± 14.7;
p¼ 0.005), had lower BMI (25.1 ± 3.9 vs. 27.7 ± 5.3;
p¼ 0.048), lower percentage of body fat (19.8 ± 8.1% vs.
28.1 ± 10%; p¼ 0.001), lower truncal fat mass (16.8 ± 10.7
vs. 26.4 ± 10.5; p¼ 0.001), lower albumin (3.4 ± 0.5 g/dL vs.
3.9 ± 3.3 g/dL; p¼ 0.0001), lower triglyceride (147.9 ± 88.5
vs. 182.1 ± 97.7 mg/dL; p¼ 0.03) and total cholesterol
(146.9 ± 34.5 vs. 169.5 ± 43 mg/dL; p¼ 0.004) (Figure 2).
C-reactive protein, EF, HD vintage, Kt/v urea and other
metabolic parameters were not different between patients with
PH and with no PH (Table 2).
A binary logistic regression analysis model, in which PH is
defined as dependent variable, age, body fat percent, albumin,
triglyceride, and total cholesterol levels as independent
variables, revealed that increased body fat percent, albumin,
and total cholesterol levels were associated with a decreased
risk of pulmonary hypertension (Table 3).
Discussion
Present study revealed a high prevalence (26.8%) of PH in HD
patients that was in similar range (17–56%) previously
reported in literature.4–9 Patients with PH were older than
patients with normal PAP (68.3 ± 14.4 vs. 61.3 ± 14.7;
p¼ 0.005). In accordance with our findings age related
Figure 2. Comparison of age, body fat percent (%), albumin (g/dL), and total cholesterol (mg/dL) levels between patients with and without PH.
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increase in PAP is shown in normal population and in HD
patients previously.21,22
Patients with PH had lower BMI, lower percentage of body
fat and truncal fat mass, albumin, triglyceride, and total
cholesterol levels than patients with normal PAP in present
study. On the other side, CRP levels were similar between two
groups. Those findings suggest a relationship between
wasting and PH in HD patients independent of inflammation.
To our knowledge, there is barely any previous report that
demonstrates an association between nutritional parameters
and pulmonary hypertension. Nevertheless Nascimento
et al.23 reported a close relationship between lung function,
inflammation, and malnutrition in patients with CKD. They
suggest that malnutrition and inflammation are associated
with a loss of muscle mass and that may also affect
respiratory muscles, potentially contributing to impaired
pulmonary function in patients with CKD. Their findings
are supported by Yoon et al.24 with a similar investigation in
106 HD patients. They showed that malnourished HD patients
had higher CRP levels, older age, lower forced vital capacity
(FVC), and forced expiratory volume 1 (FEV1) in spirometry
than normal patients on HD. Relationship between pulmonary
functions (spirometry) and pulmonary hypertension in HD
patients is not studied previously. Although Grossman et al.25
could not demonstrate a correlation between spirometry and
PAP in young healthy subjects, a possible association between
malnutrition, pulmonary functions, and PAP in HD patients is
needed to be further investigated.
Present data suggests a correlation between malnutrition
and PH in HD patients. It is well known that many patients
with ESRD have protein-calorie malnutrition, with the
reported frequency ranging from 23 to 73%.26,27 Stenvinkel
et al.28 described different types of malnutrition in uremic
patients. One of that malnutrition associated with inflamma-
tion (type 2) and second non-inflammatory malnutrition (type
1), which associates with low intake of protein and energy due
to uremic anorexia, under dialysis and physical inactivity. In
the present study, HD patients having PH had similar CRP
levels with patients having normal PAP. Therefore, they could
be classified as type 1 malnourished group. Yoo et al.15
reported a higher mortality rate in HD patients with PH who
also had low albumin levels than patients with PH and normal
albumin levels. They showed lower albumin levels in patients
with PH than having normal PAP and suggested that
hemodilution as the presumable mechanism to explain the
propensity to having lower albumin level in PH group.
However, in the present study, combined lower levels of
albumin, triglyceride, and cholesterol levels and lower BMI in
the PH group suggests malnutrition rather than hemodilution
should be underlying mechanism of hypoalbuminemia. In
concordance with our results, Mousavi et al.29 demonstrated
an association between low serum albumin, hemoglobin
levels, and PH in HD patients. As difference in hemoglobin
levels was similar between patients with and without PH in
our study, Akmal et al.30 proved that increased parathyroid
hormone (PTH) levels in CKD could cause calcification of
pulmonary artery and leading to PH. We could not detect a
difference in parameters, PTH, calcium, phosphorus, Ca P
product and 25-OH vitamin D levels between patients having
PH and normal PAP. All patients involved in the present study
were undergoing HD via active brachiocephalic arteriovenous
fistulas at the time of the study. Previously blood flow of the
fistula is suggested to be a major cause of PH in some
studies.8,31,32 Yigla and co-workers9 proved that an increase
in the flow of the fistula is positively correlated with an
increase in EF and subsequently increase in PAP. Havlucu
et al.5 demonstrated that HD patients with PH had high EF
and they attributed this finding to increase in blood flow of
fistula, anemia, and secondary hypervolemia due to CKD. In
contrast to those findings, Fadaii et al.22 detected a lower EF
in HD patients with higher PAP. Although we did not measure
the flow rate of the fistulas, EF was not different between
patients with and without PH.
As an inverse perspective, pulmonary hypertension itself
could be reason for cachexia and malnutrition. In patients
with primary PH development of cachexia is shown and
linked to an increased production of putative satiety hormone
(PYY-36).33 The gut hormone PYY-36 acts as a terminator of
hunger, reduces appetite, and 24 h food intake by binding
to neuropeptide Y, Y2 receptor in the hypothalamic arcuate
nucleus.34 A recent investigation revealed a progressive
decrease in body weight after experimentally induced PH in
mice.35 Those evidences suggest that wasting might be a
result of PH rather than being a cause. On the other hand,
cytokines may have a major role in the development of both
Table 2. Clinical, laboratory, and bioimpedance data in groups of HD
patients with and without PH.
PAP
35 mmHg
PAP
535 mmHg p
Number of patients 48 (26.8%) 131 (73.2%)
Age 68.3 ± 14.4 61.3 ± 14.7 0.005
C-reactive protein (mg/L) 18,2 ± 17 16.2 ± 16.8 NS
Body-mass Index (kg/m2) 25.1 ± 3.9 27.7 ± 5.3 0.048
Percent body fat (%) 19.7 ± 8 28.1 ± 10 0.001
PAP (mmHg) 44.4 ± 11.3 22.5 ± 5.4 0.0001
Total body water (L) 38.6 ± 9.6 37.3 ± 8.2 NS
25-OH vitamin D (mg/L) 14.4 ± 6.4 13.7 ± 5.7 NS
Dry body weight (kg) 66.5 ± 16.6 71.5 ± 16.3 NS
Calcium (mg/dL) 8.8 ± 1.1 8.9 ± 0.6 NS
Phosphorus (mg/dL) 4.6 ± 1.8 4.6 ± 1.6 NS
PTH (pg/mL) 233.9 ± 196.6 211.8 ± 236.5 NS
Ferritin (ng/mL) 717.2 ± 502.1 786.2 ± 488.1 NS
Triglyceride (mg/dL) 147.9 ± 88.5 182.1 ± 97.7 0.03
Total cholesterol (mg/dL) 146.9 ± 34.5 169.5 ± 43.1 0.004
Left ventricular EF (%) 57.2 ± 11.9 60.8 ± 9.9 NS
Dialysis vintage (months) 40 ± 37.2 54.3 ± 52.6 NS
Kt/v 1.38 ± 0.22 1.46 ± 0.23 NS
Albumin (g/dL) 3.37 ± 0.5 3.9 ± 3.3 0.0001
Hemoglobin (g/dL) 11.3 ± 1.3 11.6 ± 1.2 NS
Venous bicarbonate (meq/L) 19.5 ± 3.5 21.2 ± 2.5 NS
Table 3. Binary logistic regression analysis model; effects
of different parameters on dependent variable pulmonary
hypertension.
p Odd’s ratio
Age 0.205 1.032
Percent body fat (%) 0.002 0.874
Triglyceride (mg/dL) 0.119 1.007
Total cholesterol (mg/dL) 0.014 0.972
Albumin (g/dL) 0.036 0.074
Constant 0.016 258807.4
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PH and wasting at the same time. A recent investigation in
patients with heart failure revealed a direct correlation
between cytokines (TNF-a, IL-6, hsCRP, and NT-proBNP)
and PAP.36 Findings of present study is not enough to make a
comment about the direction of cause-effect relationship
between wasting and PH; however, those results are first to
draw attention to the existence of such a correlation between
PH and malnutrition independent of inflammation.
In conclusion, the present study demonstrated first time a
negative association between nutritional parameters and PH
in HD patients. Our study had some limitations, first study
design was cross-sectional and so we have no change to make
a comment about malnutrition and pulmonary hypertension
which was prior? Second, we did not detect the levels of other
inflammatory proteins, such as TNF-alpha, IL-6, fibrinogen.
Third, we did not perform spirometric analyses and their
correlation with PAP. Fourth, our HD patient population is
merely old and results could not be generalized for younger
patient groups. Further, prospective controlled studies are
needed to confirm our results and enlighten the direction of
this complex relationship.
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